$REGN 3 SEC Filings

Filed On	Filing
08 Feb 2024	Form 3: Pitofsky Jason, Vice President, Controller Holds 4,204 shares of Common Stock
12 Sep 2023	Form 3: Schenkein David P, Director No securities owned
12 Sep 2023	Form 3: Guarini Kathryn, Director No securities owned
05 Oct 2022	Form 3: Thompson Craig B., Director No securities owned
11 Feb 2021	Form 3: Regeneron PHARMACEUTICALS, Inc., 10% owner · Decibel Therapeutics, Inc.
13 Dec 2019	Form 3: Murphy Andrew J, EVP Research Holds 45,326 shares of Common Stock
12 Feb 2018	Form 3: McCourt Marion, SVP Commercial No securities owned
02 Mar 2017	Form 3: Fenimore Christopher R., VP, Controller Holds 1,328 shares of Common Stock
31 Jan 2017	Form 3: Coles N Anthony, Director No securities owned
12 Sep 2016	Form 3: Zoghbi Huda Y, Director No securities owned
12 Sep 2016	Form 3: Bassler Bonnie L, Director No securities owned
30 Jul 2014	Form 3: Regeneron Pharmaceuticals Inc, 10% owner · Adverum Biotechnologies, Inc.
08 Apr 2014	Form 3: Ingram Robert Alexander, Director No securities owned
11 Sep 2013	Form 3: Landry Robert E, SVP Fin, Dep CFO No securities owned
22 Nov 2011	Form 3: Tessier-Lavigne Marc, Director No securities owned
02 Sep 2011	Form 3: Larosa Joseph J, SVP Gen Counsel & Secretary No securities owned
15 Nov 2010	Form 3: Poon Christine A, Director No securities owned
24 Mar 2010	Form 3: Aberman Michael S, VP, Strat and Invest Relations No securities owned
15 Apr 2009	Form 3: Dworkin Peter, VP Investor Relations & Commun
21 Dec 2007	Form 3: Sanofi-aventis, 10% owner and 1 other Holds 14,799,552 shares of Common Stock, $.001 par value

Comments